This inventor holds 3 USPTO granted patents. Top assignees: Salsbury Chemicals, Inc., Deltagen Research Labs, LLC, Icos Corporation. Active years: 2001-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2005
Title: The Innovative Contributions of David John Fairfax
Introduction
David John Fairfax is a notable inventor based in Delmar, NY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Fairfax has made strides in developing innovative compounds and processes that have the potential to impact medical treatments.
Latest Patents
Among his latest patents, one focuses on PARP inhibitors. This invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof, along with compositions and methods for their production and use. The patent details compounds of a specific formula, including pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. Another patent involves a process for preparing piperazine-substituted aliphatic carboxylates, which outlines a method for synthesizing these compounds with a defined formula.
Career Highlights
Throughout his career, David John Fairfax has worked with several prominent companies, including Salsbury Chemicals, Inc. and Icos Corporation. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and has facilitated his innovative work.
Collaborations
Fairfax has collaborated with notable colleagues such as Erik T Michalson and Graham Beaton. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.
Conclusion
David John Fairfax exemplifies the spirit of innovation in the pharmaceutical field through his patents and collaborations. His work continues to pave the way for advancements in medical treatments and compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile